Literature DB >> 10648623

The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation.

K Wu1, S Y Fuchs, A Chen, P Tan, C Gomez, Z Ronai, Z Q Pan.   

Abstract

We describe a purified ubiquitination system capable of rapidly catalyzing the covalent linkage of polyubiquitin chains onto a model substrate, phosphorylated IkappaBalpha. The initial ubiquitin transfer and subsequent polymerization steps of this reaction require the coordinated action of Cdc34 and the SCF(HOS/beta-TRCP)-ROC1 E3 ligase complex, comprised of four subunits (Skp1, cullin 1 [CUL1], HOS/beta-TRCP, and ROC1). Deletion analysis reveals that the N terminus of CUL1 is both necessary and sufficient for binding Skp1 but is devoid of ROC1-binding activity and, hence, is inactive in catalyzing ubiquitin ligation. Consistent with this, introduction of the N-terminal CUL1 polypeptide into cells blocks the tumor necrosis factor alpha-induced and SCF-mediated degradation of IkappaB by forming catalytically inactive complexes lacking ROC1. In contrast, the C terminus of CUL1 alone interacts with ROC1 through a region containing the cullin consensus domain, to form a complex fully active in supporting ubiquitin polymerization. These results suggest the mode of action of SCF-ROC1, where CUL1 serves as a dual-function molecule that recruits an F-box protein for substrate targeting through Skp1 at its N terminus, while the C terminus of CUL1 binds ROC1 to assemble a core ubiquitin ligase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648623      PMCID: PMC85290          DOI: 10.1128/MCB.20.4.1382-1393.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation.

Authors:  E Zandi; D M Rothwarf; M Delhase; M Hayakawa; M Karin
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

2.  IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

Authors:  J D Woronicz; X Gao; Z Cao; M Rothe; D V Goeddel
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p.

Authors:  R M Feldman; C C Correll; K B Kaplan; R J Deshaies
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

4.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

Review 5.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

6.  Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast.

Authors:  E E Patton; A R Willems; D Sa; L Kuras; D Thomas; K L Craig; M Tyers
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

7.  Mass spectrometric analysis of the anaphase-promoting complex from yeast: identification of a subunit related to cullins.

Authors:  W Zachariae; A Shevchenko; P D Andrews; R Ciosk; M Galova; M J Stark; M Mann; K Nasmyth
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

8.  Identification of a cullin homology region in a subunit of the anaphase-promoting complex.

Authors:  H Yu; J M Peters; R W King; A M Page; P Hieter; M W Kirschner
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

9.  Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

Authors:  K M Lonergan; O Iliopoulos; M Ohh; T Kamura; R C Conaway; J W Conaway; W G Kaelin
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

10.  Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A.

Authors:  J J Michel; Y Xiong
Journal:  Cell Growth Differ       Date:  1998-06
View more
  49 in total

1.  CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex.

Authors:  Dora C Dias; Georgia Dolios; Rong Wang; Zhen-Qiang Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-12       Impact factor: 11.205

2.  Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

Authors:  Dongping Wei; Hua Li; Jie Yu; Jonathan T Sebolt; Lili Zhao; Theodore S Lawrence; Peter G Smith; Meredith A Morgan; Yi Sun
Journal:  Cancer Res       Date:  2011-11-09       Impact factor: 12.701

3.  Dual mode of degradation of Cdc25 A phosphatase.

Authors:  Maddalena Donzelli; Massimo Squatrito; Dvora Ganoth; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

4.  FBXO25-associated nuclear domains: a novel subnuclear structure.

Authors:  Adriana O Manfiolli; Ana Leticia G C Maragno; Munira M A Baqui; Sami Yokoo; Felipe R Teixeira; Eduardo B Oliveira; Marcelo D Gomes
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

5.  Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate.

Authors:  Kenneth Wu; Jordan Kovacev; Zhen-Qiang Pan
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

6.  Induction of cell senescence by targeting to Cullin-RING Ligases (CRLs) for effective cancer therapy.

Authors:  Yongfu Pan; Hua Xu; Rujiao Liu; Lijun Jia
Journal:  Int J Biochem Mol Biol       Date:  2012-09-25

7.  Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.

Authors:  Lijun Jia; Hua Li; Yi Sun
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

8.  Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.

Authors:  Hua Li; Mingjia Tan; Lijun Jia; Dongping Wei; Yongchao Zhao; Guoan Chen; Jie Xu; Lili Zhao; Dafydd Thomas; David G Beer; Yi Sun
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

Review 9.  Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

Authors:  Chuan-Ming Xie; Wenyi Wei; Yi Sun
Journal:  J Genet Genomics       Date:  2013-02-10       Impact factor: 4.275

Review 10.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.